Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, February 09, 2016
Cirrus Pharmaceuticals, a Kemwell company, has announced that it is ready to launch its services for manufacturing cGMP materials for early phase clinical trials in its newly constructed state-of-the-art flexi-suite at its Raleigh-Durham, USA, site.
read more
Wednesday, February 10, 2016
Velesco Pharma, an early stage pharmaceutical development and clinical manufacturing company, has boosted its cGMP analytical testing capabilities with an expansion of its analytical laboratory in Plymouth, Mich.
read more
Thursday, February 11, 2016
Crown Bioscience Inc. has reached an agreement with UK’s University of York to exclusively license and commercialize the university’s unique collection of patient-derived xenograft (PDX) models for prostate cancer.
read more
Thursday, February 11, 2016
Lonza Houston, Inc., a viral gene therapy manufacturing company, and Renova™ Therapeutics, a biopharmaceutical company developing gene therapy treatments for congestive heart failure and other chronic diseases, have entered into a Manufacturing ...
read more
Thursday, February 11, 2016
Quintiles Transnational Holdings Inc. has reported its financial results for the quarter and year ended December 31, 2015.
read more
Friday, February 12, 2016
AAIPharma Services Corp./Cambridge Major Laboratories, Inc. (AAI/CML), a leading provider of custom manufacturing and development services for the pharmaceutical and biotechnology industries, has announced expanded sterile fill-finish capabilities ...
read more
Tuesday, February 16, 2016
Bilcare Research Inc., a division of one of the world’s largest manufacturers of blister packaging solutions, has begun segregating pharma-related production operations from those servicing other industries at its Wilmington, DE facility.
read more
Tuesday, February 16, 2016
As next-generation drugs require perfectly aligned manufacturing processes and packaging solutions, leading suppliers have announced the creation of the Matrix Alliance. Their mission is to bring to market complete and compelling solutions for ...
read more
Tuesday, February 16, 2016
Philogen S.p.A. has entered into a second collaboration with AbbVie to discover and develop novel types of armed antibody products.
read more
Tuesday, February 16, 2016
Capsugel and Pulmatrix have formed a collaboration to develop novel inhaled therapeutics to treat serious pulmonary diseases. The agreement provides Capsugel exclusive rights to manufacture clinical trial and commercial batches of iSPERSE™-based ...
read more
Wednesday, February 17, 2016
Impax Laboratories has announced that the U.S. Food and Drug Administration (FDA) has approved its Abbreviated New Drug Application (ANDA) for dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine ...
read more
Wednesday, February 17, 2016
Aldevron, a provider of products and contract manufacturing services for the pharmaceutical and biotechnology industries, announces the appointment of Jenny Stafford as Vice President and General Manager. Ms. Stafford’s responsibilities include ...
read more
Wednesday, February 17, 2016
Asterand Bioscience has been awarded a five-year, $6.5M contract from the National Institutes of Health (NIH) to provide oncology specimens with associated clinical data to the Clinical Proteomic Tumor Analysis Consortium (CPTAC).
read more
Wednesday, February 17, 2016
AMRI has reported financial and operating results for the fourth quarter and full year ended December 31, 2015 and provided an outlook for 2016.
read more
Thursday, February 18, 2016
AAIPharma Services Corp./Cambridge Major Laboratories a provider of custom manufacturing and development services for the pharmaceutical and biotechnology industries, has announced the planned investment of at least $10.7 Million to relocate its St. ...
read more